Table 2.
Implementation N (%) of CONSORT-A in 212 reports of published RCTs in the field of implantology
| CONSORT criterion | Implementation N (%) degree of adherence I |
Implementation N (%) degree of adherence II |
| Identification as a randomised trial in the title | 95 (45) | 95 (45)* |
| Trial design | 66 (31) | 66 (31)* |
| Participant characteristics | 154 (73) | 154 (73)* |
| Interventions | 212 (100) | 200 (94) |
| Objective | 209 (99) | 209 (99)* |
| Definition primary endpoint | 198 (93) | 117 (55) |
| Randomisation | 35 (17) | 13 (6) |
| Blinding | 41 (19) | 21 (10) |
| Numbers randomised | 97 (46) | 97 (46)* |
| Recruitment | 196 (93) | 196 (93)* |
| Numbers analysed | 57 (27) | 57 (27)* |
| Results of outcome | 207 (98) | 133 (63) |
| Harms | 23 (11) | 23 (11)* |
| Conclusion | 204 (96) | 47 (22) |
| Trial registration | 10 (5) | 10 (5)* |
| Funding | 8 (4) | 8 (4)* |
| Total |
Presentation of the degree of adherence I (information given in the abstract) and degree of adherence II (correct documentation in accordance with CONSORT-A).
*Variables without a formal degree of adherence II.
CONSORT, Consolidated Standards of Reporting Trials; CONSORT-A, CONSORT criteria for abstracts; RCTs, randomised controlled trials.